Advanced Biomed Inc. (ADVB)

Advanced Biomed will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $5.00
Shares Offered
Deal Size
Chart not available yet
Data will show when the stock starts trading.
Market Cap 562.50M
Revenue (ttm) n/a
Net Income (ttm) -4.75M
Shares Out 125.00M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About ADVB

Advanced Biomed is committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 38
Stock Exchange NASDAQ
Ticker Symbol ADVB
Full Company Profile

Financial Performance

Financial Statements


Advanced Biomed sets IPO terms, which could value the biotech at up to $625 million

Advanced Biomed Inc. ADVB, has set terms for its initial public offering, in which the Taiwan-based biotechnology company focused on treating cancer is looking to raise up to $125 million. The company...

11 months ago - Market Watch

Advanced Biomed IPO Registration Document (S-1)

Advanced Biomed has filed to go public with an IPO on the NASDAQ.

1 year ago - SEC